About The Project

Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project on Github | Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project on Facebook | Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project on Twitter

The Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project is an open source project with the goals of leveraging Artificial Intelligence to help detect AML/ALL and discover potential candidates for drugs to help combat the diseases.
This project is in memory of Peter Edward Moss who lost his battle with Acute Myeloid Leukemia in August 2019. The project is run entirely by volunteers and is not a registered Non Profit.

Find Out More...

Project History

The Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project was created after Peter was diagnosed with Acute Myeloid Leukemia and given a few weeks to live. At the time there was little in depth information/datasets easily available online or through the doctors. A Facebook post by one of Peter's grandsons, Adam Milton-Barker, in Artificial Intelligence & Deep Learning (AIDL) Group on Facebook brought the project to the attention of Ho Leung Ng, Associate Professor of Biochemistry & Molecular Biophysics at Kansas State University. As a leukemia researcher, Ho was able to share information of datasets, research papers and access to people who are researching/volunteering their time/experience to early detection and drug discovery for Acute Myeloid and Lymphoblastic Leukemia.

During a visit to his family in the United States, Adam was able to speak to doctors at the Hematology Oncology Center in Port St Lucie, one of the centers that assisted Peter during his battle with AML. They explained a lot of things including how with AML, there is no known warning signs so early detection is very hard, if not impossible. In Peter's case the disease was completely missed in a standard blood test 1 month before being diagnosed as blood tests were all clear. It may be possible that something was missed, and AI may be the perfect tool to find that something.

The advice that the doctors gave in Port St Lucie was to try to work backwards from the point of diagnosis, trying to catch some sort of pattern, or anything that was missed during the previous test. AI is good at seeing patterns we as humans may miss, but the problem is getting hold of the right type of data needed for convolutional neural networks, or AI network of any kind. The obvious privacy restrictions means that it is not easy to obtain data, therefore the project relies on the help of others in the field who have dedicated their time to create open datasets.

TThe project is being coordinated by a group of volunteers with experience in computer vision / natural language processing, Leukemia research, Biochemistry, Molecular Biophysics, Immunology and Bioinformation.

Meet Our Team...

The Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project team is a group of volunteers with experience in computer vision / natural language processing, Leukemia research, Biochemistry, Molecular Biophysics, Immunology and Bioinformation.

This project is run entirely by volunteers and is not a registered Non Profit.

420

Adam Milton-Barker

Adam Milton-Barker

Project Founder
Intel Software Innovator

Adam Milton-Barker is Peter's eldest grandson and Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project Founder.

Find out more...

393

Prof. Ho Leung Ng

Prof. Ho Leung Ng

Project Co-Founder, Student Mentor & R&D
Intel Software Innovator

Prof. Ho Leung Ng is one of the three founding team members of the Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project and oversees the Peter Moss AML/ALL AI Student Program.

Find out more...

466

Prof. Amita Kapoor

Prof. Amita Kapoor

Project Co-Founder, Student Mentor & R&D
Intel Software Innovator

Prof. Amita Kapoor is one of the three founding team members of the Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project and oversees the Peter Moss AML/ALL AI Student Program.

Find out more...

451

Estela Cabezas

Estela Cabezas

Leukemia / AI R&D
Intel Software Innovator

Estela was introduced to the project by Adam in early 2019 to get assistance from the team for her thesis. Since then Estela has volunteered her time to 3 events representing the project, and her second time representing the project as an Intel Software Innovator.

Find out more...

554

Salvatore Raieli

Salvatore Raieli

Leukemia / AI R&D

Salvatore Raieli joined the Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project in 2019. Since then Salvatore has contributed towards the project Github repositories providing code for using Fast AI for classifying Acute Lymphoblastic Leukemia.

Find out more...

451

Rishabh Banga

Rishabh Banga

Leukemia / AI R&D
Intel Software Innovator

Rishabh Banga joined the Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project in 2019.

Find out more...

What We Are Working On...

Detection

The project focuses mainly on Convolutional Neural Networks & Generative Adversarial Networks for detecting AML/ALL. We are researching and developing a number of implementations/solutions to compare and find the most effective.

More Info... | Classifiers Repository

Drug Discovery

One of the areas that the drug discovery R&D focuses on is the use of Generative Adversarial Networks (GANs) in drug discovery. The Drug Discovery Team are creating multiple implementations/solutions to compare and find the most effective.

More Info... | Drug Discovery Repository

Natural Language

We look into the use of Natural Linguistics to assist Acute Myeloid / Lymphoblastic Leukemia patients and family. We are researching and developing a number of implementations/solutions to compare and find the most effective.

More Info... | Conversational Agents Repository

The project is being coordinated by a group of volunteers with experience in computer vision / natural language processing, Leukemia research, Biochemistry, Molecular Biophysics, Immunology and Bioinformation.

The purpose of the project is to share public information related to AML/ALL, as well as open source projects including dectection with convolutional neural networks, using natural language understanding for AML/ALL chatbots, and R&D for discovering potential candidates for drugs for AML/ALL.

Tribute Gallery

A tribute to Peter sharing moments in his life that have been shared by family & friends.

TVR Griffith 200

TVR Griffith 200
299
In Memory Of Peter Edward Moss

One of Peter Moss's life long passions was auto engineering and cars! One of the places he worked was TVR, a company born in Blackpool. Peter was part of the team that engineered the TVR Griffith 200. Here is a photo of the TVR Griffith 200.

  

TVR Business Card

TVR Business Card
252
In Memory Of Peter Edward Moss

One of Peter Moss's life long passions was auto engineering and cars! One of the places he worked was TVR, a company born in Blackpool. Peter was part of the team that engineered the TVR Griffith 200. Here is Peter's TVR business card.

  

80th Birthday Party August 2019

80th Birthday Party August 2019
252
In Memory Of Peter Edward Moss

Peter's 80th birthday party. 4th August 2019.

  

Peter Moss AML/ALL AI Research Project

The Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project is an open source project with the goals of leveraging Artificial Intelligence to help detect AML/ALL and discover potential candidates for drugs to help combat the diseases.

This project is in memory of Peter Edward Moss who lost his battle with Acute Myeloid Leukemia in August 2019.

© Peter Moss AML & ALL AI Research Project 2018. All Rights Reserved.
This project is entirely volunteer and is not a registered Non Profit.
Contact | Terms & Conditions | Privacy & Cookie Policy | Disclaimer | High Level A+ Encryption